New Results
Potential inhibitors for 2019-nCoV coronavirus M protease from clinically approved medicines
Xin Liu, Xiu-Jie Wang
doi: https://doi.org/10.1101/2020.01.29.924100
Xin Liu
1Key Laboratory of Genetic Network Biology, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing, China
Xiu-Jie Wang
1Key Laboratory of Genetic Network Biology, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing, China
2University of Chinese Academy of Sciences, Beijing, China
3Innovation Academy for Seed Design, Chinese Academy of Sciences, Beijing, China

Article usage
Posted January 29, 2020.
Potential inhibitors for 2019-nCoV coronavirus M protease from clinically approved medicines
Xin Liu, Xiu-Jie Wang
bioRxiv 2020.01.29.924100; doi: https://doi.org/10.1101/2020.01.29.924100
Subject Area
Subject Areas
- Biochemistry (7329)
- Bioengineering (5301)
- Bioinformatics (20212)
- Biophysics (9985)
- Cancer Biology (7706)
- Cell Biology (11273)
- Clinical Trials (138)
- Developmental Biology (6425)
- Ecology (9923)
- Epidemiology (2065)
- Evolutionary Biology (13292)
- Genetics (9353)
- Genomics (12559)
- Immunology (7681)
- Microbiology (18964)
- Molecular Biology (7421)
- Neuroscience (40915)
- Paleontology (298)
- Pathology (1226)
- Pharmacology and Toxicology (2130)
- Physiology (3145)
- Plant Biology (6842)
- Synthetic Biology (1893)
- Systems Biology (5299)
- Zoology (1086)